Picture of Carmat SA logo

ALCAR Carmat SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Carmat's Financial Horizon Extends To End-May; Co Reiterates Confidence In Its 2024 Outlook

May 6 (Reuters) - Carmat SA  ALCAR.PA :
    * CARMAT CONTINUES TO BUILD ON ITS MOMENTUM IN THE EFICAS
STUDY
AND REITERATES CONFIDENCE IN ITS 2024 OUTLOOK
    * CONFIRMATION OF SHORT-TERM FINANCIAL SUPPORT FROM SEVERAL
KEY
SHAREHOLDERS
    * EFICAS STUDY REACHES MILESTONE OF 20 IMPLANTS
    * INTERIM STUDY RESULTS ABOVE EXPECTATIONS
    * CONFIRMS ITS TARGET OF COMPLETING EFICAS STUDY, WITH A
TOTAL OF
52 AESON IMPLANTS, IN FIRST HALF OF 2025
    * GIVEN ITS CASH POSITION AND BUSINESS PLAN, COMPANY'S
FINANCIAL
HORIZON CURRENTLY EXTENDS TO END OF MAY 2024
    * ESTIMATES ITS 12-MONTH FINANCING REQUIREMENT AT AROUND EUR
45
MILLION

Source text for Eikon:  ID:nBw215xc0a 
Further company coverage:  ALCAR.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Carmat SA

See all news